Clinical Trial Update: suPAR is a Potential Biomarker of in Chronic Periodontitis Through the Impact of Post-radiotherapy on HNCs Patients

View source ↗

Summary

Clinical trial update examining suPAR as a biomarker for chronic periodontitis and the impact of post-radiotherapy in head and neck cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Periodontitis

Snippet

Sponsor: Al-Maarif University College | Conditions: Head and Neck Cancer, Chronic Periodontitis | Status: COMPLETED